Interpretable deep learning radiomics from (18)F-FDG PET/CT for differentiating diffuse large B-cell lymphoma and follicular lymphoma

利用 (18)F-FDG PET/CT 进行可解释的深度学习放射组学分析,以鉴别弥漫性大B细胞淋巴瘤和滤泡性淋巴瘤

阅读:1

Abstract

OBJECTIVE: To develop and validate interpretable models integrating standardized uptake value (SUV), radiomics (Rad), and deep learning (DL) features from (18)F-FDG PET/CT for differentiating diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). METHODS: This retrospective study included 250 patients from two centers. Volumes of interest (VOIs) were delineated on PET images for SUV, Rad, and DL features extraction. Feature selection was performed using the Mann–Whitney U test, random forest–based recursive feature elimination, and the least absolute shrinkage and selection operator (LASSO). Seven machine learning classifiers were applied to construct diagnostic models, and fused Rad and DL features were further integrated to construct deep learning radiomics (DLR) models. Model interpretability was assessed using SHapley Additive exPlanations (SHAP). Model performance was evaluated in terms of discrimination, calibration, and clinical applicability. RESULTS: The DLR model achieved the best diagnostic performance, with an area under the curve (AUC) of 0.905 and an accuracy of 0.813 in the testing cohort. SHAP analysis identified the Rad feature “original_Maximum” as the most influential predictor for differentiating DLBCL from FL. Calibration curve and decision curve analyses further supported the superiority of the DLR model. CONCLUSION: Rad and DL features derived from (18)F-FDG PET/CT enable effective differentiation between DLBCL and FL. The proposed SHAP-based interpretable model offers superior diagnostic accuracy and potential clinical utility. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12880-026-02253-y.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。